Cancer stem cells, characterized as CD44+/CD24-/low expression and high ALDH activity, possess tumor initiation capacity, unlimited self-renewal competence and the ability of differentiating into heterogeneous cells 27. This evidence concerns the gene CD44 and neoplasm.